RS Investment Management’s Zimmer Biomet ZBH Stock Holding History

RS Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-65,933	Closed	-$6.99M	–	393
2015 Q2	$6.99M	Sell	65,933 -447	-0.7%	-$49.5K	0.06%	265
2015 Q1	$7.57M	Buy	66,380 +1,377	+2%	+$157K	0.07%	258
2014 Q4	$7.06M	Sell	65,003 -1,447	-2%	-$153K	0.06%	261
2014 Q3	$6.49M	Buy	66,450 +1,302	+2%	+$128K	0.06%	273
2014 Q2	$6.57M	Buy	65,148 +155	+0.2%	+$15.1K	0.06%	262
2014 Q1	$5.97M	Buy	64,993 +14,111	+28%	+$1.3M	0.04%	260
2013 Q4	$4.6M	Buy	+50,882	New	+$4.4M	0.03%	272

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

RS Investment Management's ZBH Position: Q3 2015 in Review

RS Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 65,933 shares — an estimated $6.99M sold.

RS Investment Management first reported a position in ZBH in Q4 2013 and held it in 7 quarters. The position peaked at $7.57M in Q1 2015. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

RS Investment Management reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
RS Investment Management sold 65,933 Zimmer Biomet shares in Q3 2015, an estimated $6.99M.
RS Investment Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 7 quarters.
RS Investment Management's Zimmer Biomet position peaked at $7.57M in Q1 2015.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on RS Investment Management's 13F filing for Q3 2015, filed 4 Nov 2015.